| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9911010536103321 |
|
|
Autore |
Herzog Eyal |
|
|
Titolo |
Cardiac Amyloidosis / / edited by Eyal Herzog |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2025.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (397 pages) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Cardiology |
Internal medicine |
Critical care medicine |
Hematology |
Internal Medicine |
Intensive Care Medicine |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Pathway for the diagnosis and management of CA -- Epidemiology and pathophysiology of CA -- Diagnosis of CA- ECG -- Diagnosis of CA- Echocardiography -- Diagnosis of CA- Nuclear imaging -- Diagnosis of CA- CMR -- Diagnosis of CA- Hematological testing -- Genetics testing in CA. Treatment of CA- heart failure -- Treatment of CA- Advanced heart failure management -- Treatment of CA- arrythmias management -- Treatment of CA- aortic stenosis management -- Treatment of CA- Disease modifying therapies -- Treatment of CA- New frontier and evolving therapies -- Hematological manifestations and treatment -- Neurology and CA -- Gastroenterology and CA -- Nephrology and CA -- Follow up of patients with CA -- Prognosis of patients with CA -- Case presentation of patients with CA using the CA pathway. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This book reviews the diagnosis and management of cardiac amyloidosis. Systemic amyloidosis is a broad spectrum of diseases that results from misfolding of proteins that aggregate into amyloid fibrils. In cardiac amyloidosis, amyloid fibrils accumulate in the interstitial space between cardiac myocytes causing cellular injury and impairing cardiac function. Cardiac Amyloidosis reviews the advances in cardiac |
|
|
|
|
|
|
|
|
|
|
imaging, diagnostic strategies and therapies available that have improved the recognition and treatment of cardiac amyloidosis. The contributors to this book have distilled the existing clinical guidelines into a novel and simple pathway to help healthcare providers diagnose and treat patients. Within this book they review each section of this pathway: suspicion, red flags, diagnosis, treatment and follow up. With current data suggesting that cardiac amyloidosis is more common than previously thought, this book is a timely addition to the literature and will be important for all healthcare professionals managing these patients. |
|
|
|
|
|
| |